PhD positions at the International Max Planck Research School in Chemical and Molecular Biology

Application Deadline: April 13th 2020

The International Max Planck Research School in Chemical and Molecular Biology (IMPRS-CMB) is looking for talented and motivated PhD candidates of all nationalities to carry out novel projects in the following research areas:

BIOCHEMISTRY • BIOPHYSICS • CANCER BIOLOGY • CELL BIOLOGY • CHEMICAL BIOLOGY • DRUG DISCOVERY • MOLECULAR BIOLOGY • NETWORK BIOLOGY • STEM CELL BIOLOGY • STRUCTURAL BIOLOGY • SYNTHETIC BIOLOGY • SYSTEMS BIOLOGY

We expect excellent academic scores, prior research experience but most importantly commitment and enthusiasm to face the many challenges of a PhD project.

The IMPRS-CMB is a joint program between the Max Planck Institute of Molecular Physiology (MPI-MP), the Technical University (TU) Dortmund, the Ruhr University Bochum (RUB) and the University of Duisburg-Essen (UDE). All four institutes are closely connected and located in the Ruhr Metropolitan Area, a vibrant, open and multicultural region in Germany.

The program was established over 15 years ago and has continuously provided high quality training in the field of life sciences combined with a collaborative, interdisciplinary and young environment, where students can lay the foundations for their future career.

We offer:

• fully-funded PhD positions (competitive salaries with social benefits)

• an international and exciting working atmosphere

• state-of-the-art research facilities

• an integrated training program that includes lectures, advanced scientific workshops, complementary skill courses and career development activities

• a mentoring program to guide and promote young scientists

For more information and to apply, please visit us at www.imprs-cmb.mpg.de

The Max Planck Society strives to ensure a workplace that embraces diversity and provides equal opportunities irrespective of gender, nationality or disabilities of the applicants.

The Max-Planck Society is committed to increasing the number of individuals with disabilities in its workforce and therefore encourages applications from such qualified individuals.

Check Also

A Revolutionary Cancer Treatment Sets New Medical Milestones

A promising cancer treatment is set to change the face of traditional therapies. Imagine a …